$NAUT News

Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript

Nautilus Biotechnology Reports Q1 2026 Results: Full Earnings Call Transcript

Nautilus Biotechnology Q1 EPS $(0.12) Beats $(0.17) Estimate

Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy

Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Guggenheim Maintains Buy on Nautilus Biotechnology, Raises Price Target to $4

Nautilus Biotechnology, Inc. Q4 2025 Earnings Call Summary

Nautilus Biotechnology Q4 Earnings Call Highlights

Nautilus Biotechnology Inc (NAUT) Q4 2025 Earnings Call Highlights: Strategic Advances and ...

Nautilus Biotechnology Inc (NASDAQ:NAUT) Reports Narrower Q4 Loss, Maintains 2027 Cash Runway

Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Nautilus Biotechnology shares are trading lower. The company reported Q4 financial results.

Nautilus Biotechnology shares are trading lower. The company reported Q4 financial results.

Nautilus Does Not Anticipate Material Revenue In 2026 From Early Access Program Engagement

Nautilus Biotechnology Q4 EPS $(0.11) Beats $(0.14) Estimate

Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026

Nautilus Biotechnology Debuts Voyager Platform To Power Iterative Mapping Of Up To 10B Intact Proteins And Proteoforms Simultaneously In Single Run

Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026